IP Library Granted Patent US 10,151,529
Granted Patent B2
US 10,151,529 · App. 14/760,095 · Granted Dec 11, 2018

Dynamic suspension drying (DSD) to control Ostwald Ripening

Inventors: Joaquim Pedro Botas (Moita, PT); David Goncalves (Loures, PT); David Martins (Charneca de Caparica, PT); Filipe Neves (Lisboa, PT); Jose Melo (Odivelas, PT); Nuno Almeida (Porto Salvo, PT)
Assignee: Hovione International LTD
F26B3/10A61K9/1682A61K9/1688A61K31/58F26B1/00F26B3/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,151,529
App. No.
14/760,095
Granted
Dec 11, 2018
Kind
B2
Abstract

The present invention relates to a process for the control of Ostwald Ripening phenomenon occurring in particle suspensions without the need for addition of stabilizing agents, by using high pressure homogenization at mild conditions in a way that no increase or decrease in particle size occurs, thus allowing the stabilization of the suspension during the isolation step in the form of a dried powder.

Claims (21)

1. A method for processing particles of a pharmaceutical ingredient in suspension comprising the steps of:

a) reducing the particle size of the pharmaceutical ingredient in the suspension under high pressure conditions by using a high pressure homogenization apparatus, wherein the suspension is formed by adding the pharmaceutical ingredient to an anti-solvent, which is any media where the pharmaceutical ingredient shows none or low solubility; and

b) isolating the particles from the suspension in the form of a powder, characterized in that during the isolation step at least a portion of the suspension is recycled to the high pressure homogenization apparatus under mild pressure conditions.

2. The method according to claim 1 wherein the high pressure condition is a pressure in the range of from 500 to 3500 bar.

3. The method according to claim 1 wherein the mild pressure condition is a pressure lower than the high pressure applied to the particle size reduction.

4. The method according to claim 2 , wherein the mild pressure condition is below 500 bar.

5. The method according to claim 1 wherein the high pressure homogenization apparatus comprises gap valve, rotor stator, ultrasonic, homogenization cell or high sheer fluid processing.

6. The method according to claim 1 wherein the particle isolation step comprises a drying process for obtaining the particles in the form of a dry powder.

7. The method according to claim 6 wherein the drying process comprises spray drying, lyophilization, evaporation to dryness or a fluid bed drying step.

8. The method according to claim 7 wherein the drying step is a spray drying process.

9. The method according to claim 1 wherein the anti-solvent is methanol, ethanol, acetone, ethyl acetate, n-heptane or water.

10. The method according to claim 1 wherein the suspension is continuously recycled to the high pressure homogenization apparatus at optimized mild pressure conditions.

11. The method according to claim 1 wherein the suspension does not contain a stabilizing agent or a surfactant.

12. The method according to claim 1 wherein there are no time constraints regarding completion of the particle isolation step.

13. The method according to claim 1 wherein the particle size is stabilized during the pharmaceutical ingredient isolation step.

14. A method of minimizing Ostwald Ripening in a process for producing powder particles of a pharmaceutical ingredient from a suspension of said pharmaceutical ingredient, wherein said process comprises the steps of:

a) reducing the particle size of the pharmaceutical ingredient in the suspension under high pressure conditions by using a high-pressure homogenization apparatus, wherein the suspension is formed by adding the pharmaceutical ingredient to an anti-solvent, which is any medium where the pharmaceutical ingredient shows none or low solubility; and

b) isolating the particles from the suspension in the form of a powder, characterized in that during the isolation step, at least a portion of the suspension is recycled to the high-pressure homogenization apparatus under mild pressure conditions.

15. A method for processing particles of a pharmaceutical ingredient in suspension comprising the steps of:

a) reducing the particle size of the pharmaceutical ingredient in the suspension under high pressure conditions by using a high pressure homogenization apparatus, wherein the suspension is formed by adding the pharmaceutical ingredient to an anti-solvent, which is any media where the pharmaceutical ingredient shows none or low solubility, such as methanol, ethanol, acetone, ethyl acetate, n-heptane or water; and

b) isolating the particles from the suspension in the form of a powder, characterized in that during the isolation step at least a portion of the suspension is recycled to the high pressure homogenization apparatus under mild pressure conditions.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded May 20, 2019
From: HOVIONE INTERNATIONAL LIMITED; HOVIONE HOLDING LIMITED
To: HOVIONE HOLDING LIMITED
Reel/Frame 049229/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2015
From: BOTAS, JOAQUIM PEDRO; GONCALVES, DAVID; MARTINS, DAVID; NEVES, FILIPE; MELO, JOSE; ALMEIDA, NUNO
To: HOVIONE INTERNATIONAL LTD
Reel/Frame 036648/0425 →
Priority Claims (1)
PT 106738 · Jan 9, 2013 · national
Continuity (1)
Related Publication 20150354891A1 · Dec 10, 2015